capsaicin has been researched along with HIV Coinfection in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Handayani, M; Hardiawan, D; Januraga, P; Juwita, MN; Kusmayanti, NA; Mambea, IY; Prameswari, HD; Prawiranegara, R; Siregar, AYM; Subronto, YW; Sukmaningrum, E; Sulaiman, N; Vadra, J; Wisaksana, R | 1 |
| Auffray, C; Barbosa Bomfim, CC; Barry Delongchamps, N; Bomsel, M; Cohen, E; Ganor, Y; Mariotton, J; Zerbib, M; Zhu, A | 1 |
| Blair, HA | 1 |
| Brown, S; Simpson, DM; Tobias, JK; Vanhove, GF | 1 |
| Cole, P; Derry, S; Moore, RA; Sven-Rice, A; Tan, T | 1 |
| Katz, NP; Mou, J; Paillard, F; Stoker, M; Trudeau, J; Turnbull, B | 1 |
| Cole, P; Derry, S; Moore, RA; Rice, AS; Tan, T | 1 |
| Brown, S; Simpson, DM; Tobias, J | 1 |
| Babbar, S; Beliveau, M; Bley, K; Chanda, S; Marier, JF; Mouksassi, MS; Vanhove, GF | 1 |
| Derry, S; Lloyd, R; McQuay, HJ; Moore, RA | 1 |
| Brown, S; Gazda, S; Lu, SP; Simpson, DM; Tobias, JK; Vanhove, GF; Webster, LR | 1 |
| Cherry, CL; Cox, S; Marshall, SJ; Phillips, TJ; Rice, AS | 1 |
| Brew, BJ; Brown, S; Clifford, DB; Conway, B; Moyle, G; Simpson, DM; Tobias, JK; Vanhove, GF | 1 |
| Bromberg, MB; Herrmann, DN | 1 |
| Hahn, K; Hauer, P; McArthur, JC; Polydefkis, M; Triolo, A | 1 |
| Ferrans, CE; Lashley, FR; Paice, JA; Pitrak, D; Shott, S; Vizgirda, V | 1 |
| Cotton, P | 1 |
6 review(s) available for capsaicin and HIV Coinfection
| Article | Year |
|---|---|
Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Pain Management; Pregabalin; Transdermal Patch; TRPV Cation Channels | 2018 |
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Ointments; Pain, Postoperative; Randomized Controlled Trials as Topic | 2013 |
Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
Topics: Adult; Aged; Aged, 80 and over; Capsaicin; Databases, Factual; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Sensory System Agents; Time Factors; Transdermal Patch; Young Adult | 2014 |
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Pain; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Numbers Needed To Treat; Ointments; Pain, Postoperative; Randomized Controlled Trials as Topic | 2017 |
Topical capsaicin for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Ointments; Pain, Postoperative | 2009 |
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.
Topics: Analgesics; Anti-Retroviral Agents; Cannabis; Capsaicin; HIV Infections; Humans; Nerve Growth Factor; Peripheral Nervous System Diseases; Placebos; Plant Extracts; Randomized Controlled Trials as Topic; Research Design; Risk; Treatment Outcome | 2010 |
6 trial(s) available for capsaicin and HIV Coinfection
| Article | Year |
|---|---|
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Topics: Adult; Capsaicin; Double-Blind Method; Endpoint Determination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neuralgia; Neurologic Examination; Pain Management; Pain Measurement; Patient Satisfaction; Peripheral Nervous System Diseases; Sensory Receptor Cells; Skin; Transdermal Patch; Treatment Outcome | 2014 |
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Non-Narcotic; Capsaicin; Double-Blind Method; Female; HIV Infections; Humans; Male; Middle Aged; Pain; Pain Measurement; Placebos; Polyneuropathies; Surveys and Questionnaires; Treatment Outcome | 2008 |
Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.
Topics: Administration, Cutaneous; Administration, Topical; Capsaicin; Capsicum; Dosage Forms; Dose-Response Relationship, Drug; Female; Half-Life; HIV Infections; HIV-1; Humans; Kinetics; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Treatment Outcome | 2009 |
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
Topics: Administration, Cutaneous; Adult; Analgesics, Non-Narcotic; Antipruritics; Capsaicin; Double-Blind Method; Female; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Polyneuropathies | 2012 |
Topical capsaicin in the management of HIV-associated peripheral neuropathy.
Topics: Administration, Topical; Adult; Capsaicin; Double-Blind Method; Female; HIV Infections; Humans; Male; Middle Aged; Palliative Care; Peripheral Nervous System Diseases; Treatment Failure | 2000 |
Compliance problems, placebo effect cloud trials of topical analgesic.
Topics: Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Double-Blind Method; HIV Infections; Humans; Ointments; Patient Compliance; Peripheral Nervous System Diseases; Placebo Effect | 1990 |
6 other study(ies) available for capsaicin and HIV Coinfection
| Article | Year |
|---|---|
Cost of improved test and treat strategies in Indonesia.
Topics: Ambulatory Care Facilities; Anti-HIV Agents; Capsaicin; CD4 Lymphocyte Count; HIV Infections; Humans; Indonesia; Viral Load | 2023 |
TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms.
Topics: Calcitonin Gene-Related Peptide; Capsaicin; HIV Infections; Humans; Langerhans Cells; Mucous Membrane; Pain; T-Lymphocytes; TRPV Cation Channels | 2023 |
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Female; HIV Infections; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Peripheral Nervous System Diseases; Treatment Outcome; Young Adult | 2010 |
Neuropathy treatment shows promise.
Topics: Capsaicin; Drug Delivery Systems; HIV Infections; Humans; Neuralgia | 2004 |
Chili peppers, nerve regeneration, and clinical trial design.
Topics: Biomarkers; Biopsy; Capsaicin; Capsicum; Clinical Trials as Topic; Diabetic Neuropathies; HIV Infections; Humans; Nerve Fibers, Unmyelinated; Nerve Regeneration; Peripheral Nervous System Diseases; Sensory Receptor Cells; Treatment Outcome | 2007 |
Impaired reinnervation in HIV infection following experimental denervation.
Topics: Adult; Analgesics, Non-Narcotic; Antiretroviral Therapy, Highly Active; Apolipoprotein E4; Biomarkers; Capsaicin; Denervation; Female; Genetic Predisposition to Disease; Genetic Testing; HIV Infections; Humans; Male; Nerve Regeneration; Peripheral Nervous System Diseases; Predictive Value of Tests; Sensory Receptor Cells; Skin | 2007 |